JP7541730B2 - 間葉系幹細胞の創傷治癒特性を誘導するまたは改善する方法 - Google Patents

間葉系幹細胞の創傷治癒特性を誘導するまたは改善する方法 Download PDF

Info

Publication number
JP7541730B2
JP7541730B2 JP2020555404A JP2020555404A JP7541730B2 JP 7541730 B2 JP7541730 B2 JP 7541730B2 JP 2020555404 A JP2020555404 A JP 2020555404A JP 2020555404 A JP2020555404 A JP 2020555404A JP 7541730 B2 JP7541730 B2 JP 7541730B2
Authority
JP
Japan
Prior art keywords
mesenchymal stem
stem cell
cell population
umbilical cord
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020555404A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021526125A5 (https=
JP2021526125A (ja
Inventor
トアン タン ファン
ギャビン タン
Original Assignee
セルリサーチ コーポレイション プライベート リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セルリサーチ コーポレイション プライベート リミテッド filed Critical セルリサーチ コーポレイション プライベート リミテッド
Publication of JP2021526125A publication Critical patent/JP2021526125A/ja
Publication of JP2021526125A5 publication Critical patent/JP2021526125A5/ja
Priority to JP2024035680A priority Critical patent/JP2024069365A/ja
Application granted granted Critical
Publication of JP7541730B2 publication Critical patent/JP7541730B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/395—Thyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
JP2020555404A 2018-04-12 2019-04-12 間葉系幹細胞の創傷治癒特性を誘導するまたは改善する方法 Active JP7541730B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024035680A JP2024069365A (ja) 2018-04-12 2024-03-08 間葉系幹細胞の創傷治癒特性を誘導するまたは改善する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862656531P 2018-04-12 2018-04-12
US62/656,531 2018-04-12
PCT/SG2019/050204 WO2019199234A1 (en) 2018-04-12 2019-04-12 A method of inducing or improving wound healing properties of mesenchymal stem cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024035680A Division JP2024069365A (ja) 2018-04-12 2024-03-08 間葉系幹細胞の創傷治癒特性を誘導するまたは改善する方法

Publications (3)

Publication Number Publication Date
JP2021526125A JP2021526125A (ja) 2021-09-30
JP2021526125A5 JP2021526125A5 (https=) 2022-04-19
JP7541730B2 true JP7541730B2 (ja) 2024-08-29

Family

ID=68163253

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020555404A Active JP7541730B2 (ja) 2018-04-12 2019-04-12 間葉系幹細胞の創傷治癒特性を誘導するまたは改善する方法
JP2024035680A Pending JP2024069365A (ja) 2018-04-12 2024-03-08 間葉系幹細胞の創傷治癒特性を誘導するまたは改善する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024035680A Pending JP2024069365A (ja) 2018-04-12 2024-03-08 間葉系幹細胞の創傷治癒特性を誘導するまたは改善する方法

Country Status (12)

Country Link
EP (1) EP3775163A4 (https=)
JP (2) JP7541730B2 (https=)
KR (1) KR20200143399A (https=)
CN (2) CN120608017A (https=)
AU (1) AU2019250653B2 (https=)
BR (1) BR112020020092A2 (https=)
CA (1) CA3095490A1 (https=)
PH (1) PH12020551658A1 (https=)
SG (1) SG11202009687PA (https=)
TW (1) TWI882956B (https=)
WO (1) WO2019199234A1 (https=)
ZA (1) ZA202005967B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020362379A1 (en) 2019-10-08 2022-04-07 Cellresearch Corporation Pte. Ltd. A method of assessing wound healing potency of a mesenchymal stem population and related methods of selecting mesenchymal stem cells and identifying tissue as starting material for producing a mesenchymal stem cell population
WO2021071430A1 (en) * 2019-10-08 2021-04-15 Cellresearch Corporation Pte. Ltd. A mesenchymal stem cell storing or transport formulation and methods of making and using the same
WO2021257073A1 (en) * 2020-06-17 2021-12-23 Joy Kong Method for producing mesenchymal stem cells from neonatal stem cells
WO2022004938A1 (ko) * 2020-06-30 2022-01-06 주식회사 미래셀바이오 유사 중간엽 줄기세포의 제조방법
CN114196626A (zh) * 2022-02-16 2022-03-18 北京国卫生物科技有限公司 脐带间充质干细胞及其分离培养扩增方法
WO2024107102A1 (en) * 2022-11-17 2024-05-23 Cellresearch Corporation Pte. Ltd. Use of conditioned medium derived from cultivation of mesenchymal stem cells of the umbilical cord for inducing, stimulating and promoting hair growth and regeneration
WO2024123237A1 (en) * 2022-12-09 2024-06-13 Cellresearch Corporation Pte. Ltd. Use of conditioned medium of cord lining mesenchymal stem cells for healing and/or preventing the formation and/or recurrence of a wound or a damaged skin area

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007046775A1 (en) 2005-10-21 2007-04-26 Cellresearch Corporation Pte Ltd Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom
JP2014525262A (ja) 2011-08-31 2014-09-29 セウォン セロンテック カンパニー リミテッド 間葉系幹細胞の基本培養培地の調製方法、間葉系幹細胞の基本培養培地及びこれを利用して培養分化した細胞治療剤
WO2017094879A1 (ja) 2015-12-03 2017-06-08 タカラバイオ株式会社 間葉系幹細胞の製造方法
JP2019530448A (ja) 2016-10-05 2019-10-24 セルリサーチ コーポレイション プロプライエタリー リミテッド 細胞培養液を用いて臍帯羊膜から間葉系幹細胞を単離する方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1288293A1 (en) 2001-08-30 2003-03-05 Norio Sakuragawa Human neural stem cells originated from human amniotic mesenchymal cell layer
WO2004072273A1 (en) 2003-02-11 2004-08-26 Davies John E Progenitor cells from wharton's jelly of human umbilical cord
TWI287010B (en) * 2003-06-12 2007-09-21 Euro Celtique Sa Therapeutic agents useful for treating pain
PL1789534T3 (pl) 2004-08-16 2015-03-31 Cellresearch Corp Pte Ltd Wyodrębnienie komórek macierzystych/progenitorowych z błony owodniowej pępowiny
CN101189341B (zh) * 2005-04-04 2016-10-19 纳幕尔杜邦公司 用于制备抗真菌病原体的植物的多核苷酸和方法
WO2007121263A2 (en) * 2006-04-14 2007-10-25 Wako Pure Chemical Industries, Ltd Structure for introducing a plurality of solutions, micro fluidic device having said structure and method for introducing solution
US20100136681A1 (en) * 2007-04-02 2010-06-03 The General Hospital Corporation Cellular compositions for the treatment of kidney disease and uses thereof
WO2013059528A2 (en) * 2011-10-18 2013-04-25 City Of Hope Encapsulated diagnostics and therapeutics in nanoparticles-conjugated to tropic cells and methods for their use
US9670488B2 (en) * 2011-11-04 2017-06-06 Dicerna Pharmaceuticals, Inc. Methods and compositions for the specific inhibition of met by double stranded RNA
CN103301154B (zh) * 2013-04-19 2014-12-17 胡祥 脐带间充质干细胞在制备治疗红斑狼疮的制剂中的用途
CN104630142B (zh) * 2015-02-06 2018-06-05 广州赛莱拉干细胞科技股份有限公司 一种牛脐带间充质干细胞的分离及培养方法
WO2017096607A1 (zh) 2015-12-11 2017-06-15 郭镭 一种从脐带外层羊膜组织中分离提取hUC-MSC的方法
CN105420179A (zh) * 2015-12-17 2016-03-23 斯坦姆（天津）生物技术研究有限公司 一种从脐带和胎盘羊膜组织同时提取上皮细胞和间充质干细胞的方法
CN106119191A (zh) * 2016-07-05 2016-11-16 四川华皓生物科技有限公司 一种胎盘绒毛板间充质干细胞及临床化制备方法
CN106377544A (zh) * 2016-09-30 2017-02-08 广州赛莱拉干细胞科技股份有限公司 脐带间充质干细胞上清液在制备治疗口腔溃疡药物中的应用及漱口液和其制备方法
WO2019199230A1 (en) 2018-04-09 2019-10-17 Cellresearch Corporation Pte. Ltd. A method of transporting mesenchymal stem cells by means of a cell culture medium and a method of administering stem cells to wounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007046775A1 (en) 2005-10-21 2007-04-26 Cellresearch Corporation Pte Ltd Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom
JP2014525262A (ja) 2011-08-31 2014-09-29 セウォン セロンテック カンパニー リミテッド 間葉系幹細胞の基本培養培地の調製方法、間葉系幹細胞の基本培養培地及びこれを利用して培養分化した細胞治療剤
WO2017094879A1 (ja) 2015-12-03 2017-06-08 タカラバイオ株式会社 間葉系幹細胞の製造方法
JP2019530448A (ja) 2016-10-05 2019-10-24 セルリサーチ コーポレイション プロプライエタリー リミテッド 細胞培養液を用いて臍帯羊膜から間葉系幹細胞を単離する方法

Also Published As

Publication number Publication date
JP2024069365A (ja) 2024-05-21
JP2021526125A (ja) 2021-09-30
SG11202009687PA (en) 2020-10-29
CN120608017A (zh) 2025-09-09
ZA202005967B (en) 2021-08-25
EP3775163A4 (en) 2022-03-09
AU2019250653A1 (en) 2020-10-15
PH12020551658A1 (en) 2021-07-26
EP3775163A1 (en) 2021-02-17
KR20200143399A (ko) 2020-12-23
TW202012618A (zh) 2020-04-01
TWI882956B (zh) 2025-05-11
CN112262211B (zh) 2025-05-09
BR112020020092A2 (pt) 2021-02-17
CN112262211A (zh) 2021-01-22
AU2019250653B2 (en) 2025-06-19
CA3095490A1 (en) 2019-10-17
WO2019199234A1 (en) 2019-10-17

Similar Documents

Publication Publication Date Title
US12344861B2 (en) Method of isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord, a mesenchymal stem cell population isolated from the amniotic membrane of the umbilical cord and a cell culture medium for isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord
JP7541730B2 (ja) 間葉系幹細胞の創傷治癒特性を誘導するまたは改善する方法
JP2024059760A (ja) 輸送溶液によって間葉系幹細胞を輸送する方法および幹細胞を創傷に投与する方法
WO2019199230A1 (en) A method of transporting mesenchymal stem cells by means of a cell culture medium and a method of administering stem cells to wounds
US12460178B2 (en) Method of inducing or improving wound healing properties of mesenchymal stem cells
RU2783992C2 (ru) Способ выделения мезенхимальных стволовых клеток из амниотической мембраны пуповины с применением клеточной культуральной среды
HK40004787A (en) A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium
HK40004787B (en) A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201111

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20210112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210623

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220408

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220408

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230131

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230208

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230502

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230808

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20231027

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20231109

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240308

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240423

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240423

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20240515

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240716

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240809

R150 Certificate of patent or registration of utility model

Ref document number: 7541730

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150